Loading...
NPI 1891135299 · Atlanta, GA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
K&s Clinical Diagnostics Consulting Services, LLC is a clinical medical laboratory provider located in Atlanta, Georgia. This profile covers 3 Medicare and 39 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | K&s Clinical Diagnostics Consulting Services, LLC |
| Address | 1995 N Park Pl Se Ste 205 |
| City | Atlanta |
| State | GA |
| ZIP | 30339 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 28, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $621.2K |
| Medicaid | $229.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2,070 | $240 | $500.7K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 1,530 | $60 | $93.6K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 180 | $150 | $27.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
39 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 18,520 | $10 | $148.1K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 20,070 | $1 | $60.2K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 260 | $40 | $10K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,040 | $10 | $9.3K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,160 | $1 | $1.2K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 530 | $1 | $1.1K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 250 | $1 | $760 |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 240 | $1 | $730 |
| 80156 | The lab analyst performs the technical lab test to analyze a specimen for the total amount of carbamazepine, a medication clinicians use for the treatment of epilepsy and some other neurologic and… | 190 | $1 | $190 |
| 80175 | A lab tests a patient's specimen to determine the level of lamotrigine. | 190 | $1 | $190 |
Showing 1–10 of 39
How this provider's Medicaid billing volume and revenue compare to other Georgia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Georgia median
39 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 30 | 2,370 | $100 | $757.4K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 18 | 30 | 860 | $70 | $525.3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 16 | 30 | 940 | $30 | $467.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 8 | 70 | 2,840 | $30 | $428.7K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 30 | 1,130 | $50 | $338.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 20 | 30 | 820 | $20 | $154.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 11 | 20 | 350 | $10 | $52K |
| 80156 | The lab analyst performs the technical lab test to analyze a specimen for the total amount of carbamazepine, a medication clinicians use for the treatment of epilepsy and some other neurologic and… | 3 | 10 | 4,490 | $10 | $33K |
| 80201 | The lab analyst performs the technical lab test to analyze a specimen to quantitate the amount of topiramate present, which is an anticonvulsant medication. | 3 | 10 | 660 | $10 | $23.5K |
| 80361 | The lab analyst measures the amount of or detects the presence of one or more opiates, narcotic analgesics that depress the central nervous system, in the specimen. | 12 | 10 | 690 | $1 | $22.3K |
Showing 1–10 of 39
Other providers in the same ZIP code as K&s Clinical Diagnostics Consulting Services, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Ryan Whitted | GA | Ophthalmology Physician | $2.5M | $0 |
| James Frank | GA | Retina Specialist (Ophthalmology) Physician | $2.4M | $0 |
| Margaret Wong Gribble | GA | Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician | $2M | $0 |
| A Plus Pediatric Dentistry Of Atlanta | GA | Pediatric Dentistry | $0 | $637.3K |
| Crestre Boddy | GA | Clinical Social Worker | $446.8K | $0 |
| Charles Thompson | GA | Ophthalmology Physician | $405K | $23.8K |
| Christine Page | GA | Mental Health Counselor | $0 | $424K |
| Nikhil Anand | GA | Ophthalmology Physician | $404.1K | $0 |
| John Roach | GA | Ophthalmology Physician | $340.7K | $0 |
| Elliot Levine | GA | Ophthalmology Physician | $336.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.